Defence Therapeutics Inc. (OTCMKTS:DTCFF – Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 1,700 shares, a drop of 5.6% from the May 15th total of 1,800 shares. Based on an average daily volume of 300 shares, the short-interest ratio is presently 5.7 days.
Defence Therapeutics Price Performance
OTCMKTS:DTCFF opened at $0.83 on Tuesday. The company has a 50 day moving average price of $0.93 and a 200-day moving average price of $1.31. Defence Therapeutics has a 1-year low of $0.81 and a 1-year high of $3.19.
Defence Therapeutics Company Profile
Read More
- Five stocks we like better than Defence Therapeutics
- What Does Downgrade Mean in Investing?
- 6 Reasons the S&P 500 Will Keep Rising This Year
- What Are the U.K. Market Holidays? How to Invest and Trade
- CAVA’s Per-Restaurant Stock Value Outshines Chipotle’s
- Upcoming IPO Stock Lockup Period, Explained
- The Most Shorted Stocks in June: Hold, Short, or Squeeze?
Receive News & Ratings for Defence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.